Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
about
Metabolic, autophagic, and mitophagic activities in cancer initiation and progressionMitochondria and the autophagy-inflammation-cell death axis in organismal agingParkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1.Cancer and neurodegeneration: between the devil and the deep blue sea.PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cellsDiscovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis.Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.Common fragile site tumor suppressor genes and corresponding mouse models of cancer.The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and CancerThe PP2A inhibitor SET regulates granzyme B expression in human natural killer cells.Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1.Lack of association between cancer history and PARKIN genotype: a family based study in PARKIN/Parkinson's families.Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation.Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age.Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.Role of E3 ubiquitin ligases in lung cancer.An emerging role of PARK2 in cancer.Expression pattern of parkin isoforms in lung adenocarcinomas.Parkin and mitophagy in cancer.Neuronal nitric oxide synthase induction in the antitumorigenic and neurotoxic effects of 2-methoxyestradiol.Post translational modification of Parkin.The synaptic function of parkin.Contribution of germline mutations to PARK2 gene inactivation in lung adenocarcinoma.alpha-Synuclein stimulates differentiation of osteosarcoma cells: relevance to down-regulation of proteasome activity.PARK2 negatively regulates the metastasis and epithelial-mesenchymal transition of glioblastoma cells via ZEB1.A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas.Parkin induces upregulation of 40S ribosomal protein SA and posttranslational modification of cytokeratins 8 and 18 in human cervical cancer cells.Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1-Parkin pathway and modulate cellular drug response.Parkin gene alterations in ovarian carcinoma from northern Indian population.Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation.Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression.Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients.High expression of Parkin predicts easier recurrence of patients with adjuvant transarterial chemoembolization.Mitochondrial Regulation by PINK1-Parkin Signaling
P2860
Q26745503-AEB6FDD7-EB39-4324-ACB2-C364FCBDF657Q26995343-7B9E8E3A-BE99-4663-A282-1482A772FDDBQ27308731-9648E616-05A0-4CA0-9DAC-080A2D8F44A9Q33784620-3DFD8B30-F6AC-4B52-A1F6-21E935099C5CQ34093865-86DA39B6-151A-4030-ABAF-0FB78BB008DAQ34121525-222E6B57-D57C-418D-9595-4CAC7EB0E3F6Q34359802-59112331-CFF9-4CEE-9DB8-740851C94A08Q34448273-0F9AE5CE-A4DC-45F7-BC59-A94FDB2A2CB9Q34467458-6CAEF57A-AC85-4E5E-80D9-8D7E5EBF5D82Q34557827-403F6A9C-BAB6-48AE-B85F-406176A32ABAQ34576070-9AEEBDC7-AF70-4899-AB8C-BFDF49249BD1Q34707593-3853E52B-F53C-41D5-8D34-4064A61D8C26Q35562809-E0CC123D-2112-4022-8392-629959211F8EQ36288347-60694096-B017-4C0A-9934-24BBAFE74EC0Q36301055-F10071B9-3F1D-46B8-B7EA-CA4A6A3F38FFQ36823704-C9AD3603-7505-467F-A722-0A79C326AEC7Q37386688-151315E0-5158-484C-B673-C5A244340F4EQ38021865-1A438AAC-31F8-49A3-96F1-7D5951AF95E7Q38128316-15320E1E-7DD4-4EDD-BF72-EFC94DEB2ED9Q38168127-33127195-3E6B-48E2-8128-3AF7AB5386BCQ38912486-C80EDD9C-8D31-42FD-B5A9-F7CFA13D6ACCQ38946190-DCECD513-DA55-4BE0-B0D8-3C55EF428716Q38961781-1454663A-0357-4AD8-AC2F-C46D15BC8395Q39145536-3A5645A2-2CF1-441F-8717-9F980EC92D50Q39196417-4A2B699A-3A99-4D89-86EF-A18E24B25138Q39402100-7362DC8B-F130-4D3C-A98D-5DDCF083650FQ40190309-8B20EF4E-A5EF-41DB-B9FF-B334EB89D1F8Q41611419-08D112E7-32B0-47D5-B1A2-2839183B48BDQ42239902-92680B8A-A521-457A-B12C-E27E89BDB1DFQ42273308-BEB5EA0A-CB39-4726-B940-95D18FDFBFB1Q42426458-AE12A810-6166-4480-BE80-C2C479392C87Q44281189-0EA2387F-6EE7-41F6-8C05-B1CC2F1739A3Q45923538-8658342C-4F36-4CA3-89C5-AA7F8445E9A8Q46402658-6F55C6D5-43B5-4E15-92C3-7F5645BFBC91Q47132104-6D0ADB08-321A-4CD2-ADF0-55DB98426328Q48593906-DE03685A-C3A2-4CFB-8F92-4A83C8FF3859Q50236833-CA066633-7EE9-4393-B463-B3D47701CDFBQ58905388-134B540E-198D-48D6-BEE2-A672CF1FDC17
P2860
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
@en
type
label
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
@en
prefLabel
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
@en
P2093
P50
P1476
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
@en
P2093
Eric Santos Martin
George Adrian Calin
Larry R Kaiser
Manuela Sarti
Maria Cristina Picchio
Richard Fishel
Rossano Cesari
Tamotsu Kuroki
P304
P356
10.1158/1078-0432.CCR-03-0086
P407
P577
2004-04-01T00:00:00Z